EcoDrugPlus

Tryptophan Hydroxylase 1

Ensembl ID : ENSPPRG00000001846
Gene Symbol: TPH1
4 Cross references
255 Possible Orthologues:

Tubulin Alpha 1b

Ensembl ID : ENSPPRG00000001738
Gene Symbol: TUBA1B
4 Cross references
85 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSPPRG00000025015
Gene Symbol: TUBA4A
4 Cross references
224 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSPPRG00000011192
Gene Symbol: TUBB1
4 Cross references
186 Possible Orthologues:

Tubulin Beta 2a Class Iia

Ensembl ID : ENSPPRG00000023932
Gene Symbol: TUBB2A
4 Cross references
182 Possible Orthologues:

Tubulin Beta 2b Class Iib

Ensembl ID : ENSPPRG00000023755
Gene Symbol: TUBB2B
4 Cross references
181 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSPPRG00000024068
Gene Symbol: TUBB3
3 Cross references
144 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSPPRG00000005320
Gene Symbol: TUBB4B
1 Cross references
317 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSPPRG00000002545
Gene Symbol: TUBB6
4 Cross references
141 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSPPRG00000023806
Gene Symbol: TUBB
4 Cross references
333 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSPPRG00000013238
Gene Symbol: TP53
4 Cross references
253 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSPPRG00000001016
Gene Symbol: TYR
4 Cross references
266 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).